Our Facilities

BioOutsource and Cellca have state-of-the-art facilities across key geographies and in renowned life science hubs. We intend to expand our geographical reach to make our services more available to the global market.

Currently, BioOutsource has 5 facilities in the West of Scotland Science Park, Glasgow, a facility in BioCity, Newhouse, and a laboratory in Cambridge, Massachusetts, USA.

Cellca is currently based in Laupheim, Germany, while the new facility in Ulm is under construction.

 

Photo of building

Technology Terrace (HQ), Glasgow, UK

Technology Terrace was the first BioOutsource facility, which opened in 2007. This facility houses our biosafety testing and is fully cGMP compliant. We have expanded over the years, and have another 4 facilities in Glasgow, which hosts our other services, including our in-house R&D department. We also have one facility in BioCity, Newhouse, a short distance from Glasgow, which houses our cell bank manufacturing facility.


Bioanalytical Lab Boston

Bioanalytical Laboratory, Cambridge, MA, USA

Opened in 2016 to expand Sartorius Stedim BioOutsource’s bioanalytical testing services in the U.S. market. This facility houses a full range of bioanalytical testing and a selection of biosafety testing services.


 


Cellca officesLaupheim, Germany

Opened in 2005 Laupheim, Germany, the facility houses our cell line development services. Currently, our laboratories are based at the Rentschler Campus, and we have temporary offices in Laupheim while our brand new facility is under construction.

The new Cell Culture Technology Center, at Science Park III, Ulm, will double Cellca’s office and laboratory space due to an increased service demand. The facility is due to be complete by the end of 2019. You can read the press release here.

 

 

Sign-up to our newsletter to be the first to hear about our new services & offers

Sign-up to our newsletter to be the first to hear about our new services & offers

Enter your email address to subscribe to our newsletter which provides information about our services. By subscribing, you are agreeing to the processing of your personal information for this purpose as set out in our privacy policy